← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Ursure, Inc.
Bethlehem, PA
$4,508,676
Total funding
4
Grants
Funding over time
peak $1.7M · FY2017–21$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$4,508,676 · 4
By mechanism
R44$4,063,579 · 2
R43$445,097 · 2
Investigators at Ursure, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
A Point of Care Test to Monitor and Promote Adherence to Tenofovir-based regimens for the Prevention and Treatment of HIV$933,742
R44 · FY2020 · MH
A Point of Care Test to Monitor and Promote Adherence to PrEP for HIV Prevention$886,139
R44 · FY2019 · MH
A Point of Care Test to Monitor Long-Term Adherence to Tenofovir-based Regimens For The Prevention and Treatment of HIV$757,105
R44 · FY2020 · MH
A Point of Care Test to Monitor Long-Term Adherence to Tenofovir-based Regimens For The Prevention and Treatment of HIV$721,414
R44 · FY2021 · MH
A Point of Care Test to Monitor and Promote Adherence to PrEP for HIV Prevention$613,679
R44 · FY2018 · MH
A Point of Care Test to Monitor and Improve Adherence to Dolutegravir for HIV Treatment$224,874
R43 · FY2019 · MH
A Point of Care Test to Monitor and Promote Adherence to PrEP for HIV Prevention$220,223
R43 · FY2017 · MH
A Point of Care Test to Monitor and Promote Adherence to PrEP for HIV Prevention$151,500
R44 · FY2019 · MH